Exercise News and Research

Latest Exercise News and Research

Longer looks: Exercise to treat depression; crowdsourcing treatment decisions; nitroglycerin shortage

Depression is the most common mental illness - affecting a staggering 25 percent of Americans - but a growing body of research suggests that one of its best cures is cheap and ubiquitous.

28 Mar 2014

Heart attack survival rates lag behind in the South despite overall improvements nationwide

Although heart attack death has declined across all regions of the United States, it is proportionately higher in the South, possibly related to the uneven distribution of socioeconomic and traditional cardiovascular risk factors, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.

28 Mar 2014

New research reveals how good sleep can help chronic pain sufferers

Chronic pain sufferers could be kept physically active by improving the quality of their sleep, new research suggests.

28 Mar 2014

Lower levels of vitamin D predict extent of coronary artery disease

Vitamin D deficiency is an independent risk factor for heart disease with lower levels of vitamin D being associated with a higher presence and severity of coronary artery disease, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.

28 Mar 2014

Some people experience worse cholesterol levels during colder months

Cholesterol levels fluctuate based on the time of year with more unfavorable lipid profiles seen in the colder months, a trend that may be driven by related behavior changes, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.

28 Mar 2014

Formula for peak exercise heart rate does not account for differences between men and women

The formula for peak exercise heart rate that doctors have used for decades in tests to diagnose heart conditions may be flawed because it does not account for differences between men and women, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.

28 Mar 2014

Marathon training associated with improved risk factors related to cardiovascular disease

Marathon training is associated with improved risk factors related to cardiovascular disease among middle-aged recreational male runners, suggesting that race preparation may be an effective strategy for reducing heart disease risk, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session.

27 Mar 2014

Cardiome Pharma announces Q4 and full year 2013 results

Cardiome Pharma Corp. today reported financial results for the fourth quarter and year ended December 31, 2013.

27 Mar 2014

pSivida resubmits New Drug Application for ILUVIEN

pSivida Corp., a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that the New Drug Application for ILUVIEN for the treatment of chronic Diabetic Macular Edema has been resubmitted to the U.S. Food and Drug Administration (FDA).

27 Mar 2014

Contraceptive commentary: Religious liberty should not be constrained; women employees are forgotten

The Affordable Care Act returned to the Supreme Court on Tuesday, as the Justices heard a major challenge to the law's birth-control mandate. Five and maybe even six Justices across ideological lines seemed discomfited by the Administration's cramped conception of religious liberty (3/25).

27 Mar 2014

High court hears arguments regarding health law's contraception coverage requirement

The justices appeared to be divided on the question of whether companies are entitled to a religious exemption from this mandate. A decision is expected in June.

27 Mar 2014

Expert highlights the importance of gender-specific approach for treating diabetes mellitus

The international guidelines on the drug-based therapy of diabetes mellitus specify which factors need to be taken into account during treatment.

27 Mar 2014

Egalet provides business update, reports full year 2013 financial results

Egalet Corporation ("Egalet") today reported business highlights and financial results for the year ended December 31, 2013. This marks the first time that Egalet is reporting its operating results as a public company.

26 Mar 2014

High Court to hear arguments today in case mixing religious freedoms and health law's birth control coverage requirement

The case, which touches various politically charged issues, could have implications beyond the health law's birth control coverage requirement.

26 Mar 2014

People with type 2 diabetes who report good self-management behavior have reduced mortality risk

People with type 2 diabetes who report good self-management behavior have a reduced mortality risk. This was the result of a population-based study conducted by scientists at Helmholtz Zentrum München emphasizing the great importance of patient behavior in the diabetes treatment process.

26 Mar 2014

United Therapeutics' Remodulin Injection gets approval in Japan for PAH treatment

United Therapeutics Corporation today announced that Japan's Ministry of Health, Labour and Welfare has granted approval for Remodulin (treprostinil) Injection for the treatment of pulmonary arterial hypertension (PAH) by subcutaneous and intravenous administration.

26 Mar 2014

Simple blood test can predict obesity levels in children

Scientists have found that a simple blood test, which can read DNA, could be used to predict obesity levels in children.

26 Mar 2014

Research findings point to potential biomarkers for early detection of at-risk youth

Researchers at the University of California, San Diego School of Medicine have discovered impaired neuronal activity in the parts of the brain associated with anticipatory functioning among occasional 18- to 24-year-old users of stimulant drugs, such as cocaine, amphetamines and prescription drugs such as Adderall.

26 Mar 2014

BIND Therapeutics reports revenue of $2.1 million for fourth quarter 2013

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today reported financial results for the fourth quarter and year-ended December 31, 2013.

25 Mar 2014

First Edition: March 25, 2014

Today's early morning highlights from the major news organizations, including stories previewing today's Supreme Court action regarding the health law's contraception coverage mandate.

25 Mar 2014

Exercise News and Research

Latest Exercise News and Research

Longer looks: Exercise to treat depression; crowdsourcing treatment decisions; nitroglycerin shortage

Heart attack survival rates lag behind in the South despite overall improvements nationwide

New research reveals how good sleep can help chronic pain sufferers

Lower levels of vitamin D predict extent of coronary artery disease

Some people experience worse cholesterol levels during colder months

Formula for peak exercise heart rate does not account for differences between men and women

Marathon training associated with improved risk factors related to cardiovascular disease

Cardiome Pharma announces Q4 and full year 2013 results

pSivida resubmits New Drug Application for ILUVIEN

Contraceptive commentary: Religious liberty should not be constrained; women employees are forgotten

High court hears arguments regarding health law's contraception coverage requirement

Expert highlights the importance of gender-specific approach for treating diabetes mellitus

Egalet provides business update, reports full year 2013 financial results

High Court to hear arguments today in case mixing religious freedoms and health law's birth control coverage requirement

People with type 2 diabetes who report good self-management behavior have reduced mortality risk

United Therapeutics' Remodulin Injection gets approval in Japan for PAH treatment

Simple blood test can predict obesity levels in children

Research findings point to potential biomarkers for early detection of at-risk youth

BIND Therapeutics reports revenue of $2.1 million for fourth quarter 2013

First Edition: March 25, 2014

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Exercise News and Research

Latest Exercise News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in